Reaction

Exomphalos reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 535 reports · 21 co-occurring drugs

As of the last recalculation, Exomphalos appears in 535 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 118.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Zidovudine38118.9119.3
Raltegravir44112.9113.2
Darunavir3493.393.5
Lopinavir And Ritonavir2678.478.5
Ritonavir5073.373.5
Methimazole1260.860.9
Labetalol1648.148.2
Misoprostol1040.740.7
Abacavir Sulfate1040.740.7
Efavirenz1139.239.2
Emtricitabine And Tenofovir Disoproxil Fumarate4238.838.8
Nevirapine835.035.0
Atazanavir1233.233.2
Lamotirigine5331.831.9
Lamotrigine Extended-Release5331.831.9
Lamotrigine Chewable Dispersible5331.831.9
Tenofovir Disoproxil Fumarate Tablets627.327.3
Ritonavir 100 Mg1026.526.5
Levetiracetam In Sodium Chloride3921.021.1
Levetiracetam Oral3921.021.1
Levetiracetam Injection3921.021.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.